ATE207915T1 - Benzensulfonamidderivate als bradykinin antagonisten - Google Patents

Benzensulfonamidderivate als bradykinin antagonisten

Info

Publication number
ATE207915T1
ATE207915T1 AT96928492T AT96928492T ATE207915T1 AT E207915 T1 ATE207915 T1 AT E207915T1 AT 96928492 T AT96928492 T AT 96928492T AT 96928492 T AT96928492 T AT 96928492T AT E207915 T1 ATE207915 T1 AT E207915T1
Authority
AT
Austria
Prior art keywords
pct
branched
alkyl
linear
nr3r4
Prior art date
Application number
AT96928492T
Other languages
English (en)
Inventor
Pierre Dodey
Michel Bondoux
Patrick Houziaux
Martine Barth
Khan Ou
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Application granted granted Critical
Publication of ATE207915T1 publication Critical patent/ATE207915T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT96928492T 1995-08-17 1996-08-07 Benzensulfonamidderivate als bradykinin antagonisten ATE207915T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509885A FR2737892B1 (fr) 1995-08-17 1995-08-17 Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique
PCT/FR1996/001262 WO1997007115A1 (fr) 1995-08-17 1996-08-07 Derives de benzenesulfonamide comme antagonistes de la bradykinine

Publications (1)

Publication Number Publication Date
ATE207915T1 true ATE207915T1 (de) 2001-11-15

Family

ID=9481969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96928492T ATE207915T1 (de) 1995-08-17 1996-08-07 Benzensulfonamidderivate als bradykinin antagonisten

Country Status (10)

Country Link
US (1) US6080758A (de)
EP (1) EP0787131B1 (de)
JP (1) JPH10512285A (de)
AT (1) ATE207915T1 (de)
DE (1) DE69616502T2 (de)
DK (1) DK0787131T3 (de)
ES (1) ES2168501T3 (de)
FR (1) FR2737892B1 (de)
PT (1) PT787131E (de)
WO (1) WO1997007115A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19609827A1 (de) * 1996-03-13 1997-09-18 Hoechst Ag Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten
FR2751650B1 (fr) * 1996-07-24 1998-10-09 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
AU6422098A (en) * 1997-03-24 1998-10-20 Kyowa Hakko Kogyo Co. Ltd. Benzene derivatives
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
FR2765222B1 (fr) * 1997-06-27 1999-12-31 Fournier Ind & Sante Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
FR2790260B1 (fr) 1999-02-26 2001-05-04 Fournier Ind & Sante Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique
US6699486B1 (en) 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
EP1914236A1 (de) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Neue Heteroaryl-Alkylamid-Derivate als Bradykininrezeptormodulatoren
AU2003232845A1 (en) * 2002-05-29 2003-12-12 Dsm Ip Assets B.V. Method for the purification of microbial protease
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
PE20090595A1 (es) * 2007-08-15 2009-06-06 Glaxo Group Ltd Derivados de quinoliniloxipiperidina y pirrolidina como antagonistas del receptor h1
AR113839A1 (es) 2017-11-24 2020-06-17 Pharvaris B V Antagonistas del receptor b2 de bradiquinina
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
MA61123B1 (fr) 2021-08-05 2024-06-28 Pharvaris Gmbh Composition à base de lipides pour l'administration par voie orale d'antagonistes des récepteurs b2 de la bradykinine
US20250268887A1 (en) 2022-03-25 2025-08-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
ES3062067T3 (en) 2022-03-25 2026-04-08 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU686115B2 (en) * 1992-11-02 1998-02-05 Fujisawa Pharmaceutical Co., Ltd. Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds

Also Published As

Publication number Publication date
PT787131E (pt) 2002-04-29
FR2737892A1 (fr) 1997-02-21
FR2737892B1 (fr) 1997-10-24
DE69616502D1 (de) 2001-12-06
DK0787131T3 (da) 2002-02-18
EP0787131A1 (de) 1997-08-06
ES2168501T3 (es) 2002-06-16
US6080758A (en) 2000-06-27
WO1997007115A1 (fr) 1997-02-27
DE69616502T2 (de) 2002-06-06
JPH10512285A (ja) 1998-11-24
EP0787131B1 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
DE69616502D1 (de) Benzensulfonamidderivate als bradykinin antagonisten
DE69919897D1 (en) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
FI970246A7 (fi) Dihydrobentsofuraanit
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
ATE168685T1 (de) Aminoheterocyclische derivate als antithrombotische oder antikoagulierende mittel
ATE227719T1 (de) Heteroaryl-zyklische acetale
HUP0202593A2 (hu) Reverz transzkriptáz inhibitor hatású benzofenonok és ilyen vegyületeket tartalmazó gyógyászati készítmények
DE69518985D1 (de) Anwuchsverhindernde zusammensetzungen
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
IL108259A0 (en) Piperazine derivates, their preparation and pharmaceutical compositions containing them
CA2085345A1 (en) Pyrimidine nucleoside derivatives
CA2159817A1 (en) Pyrimidine Acyclonucleoside Derivatives
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
ES8800122A1 (es) Un procedimiento para la preparacion de derivados de indeno y naftaleno.
TR199700354A2 (xx) Karbohidrat t�revleri.
SE8500107D0 (sv) Neue 8alfa-acylaminoergoline
ATE374189T1 (de) Phthalazinon-derivate als pde 4 hemmer
DE69023210D1 (de) Nichtionische radiographische Kontrastmittel.
ES8604218A1 (es) Un procedimiento para la preparacion de benzoquinolicinas
DE69119409D1 (de) Vasoaktive derivate des vasotocins
NZ291855A (en) Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists
ATE233748T1 (de) Benzo(b)pyranderivate verwendbar als äusserlich anzuwendende hautbehandlungsmittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
EEWE Authorization for restitution
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee